Drug toxicity accounts for billions of lost dollars to the pharmaceutical industry each year and is a leading cause of pre-clinical drug failures. The U.S. Food and Drug Administration (FDA) and other regulatory organizations have called upon the pharmaceutical industry to develop more effective tools to help avoid these costly failures, reduce the number of […]
Roche Applied Science and NuGEN Technologies, Inc., a leader in nucleic acid sample preparation systems, announced today a co-research agreement that will enable NuGEN to develop a NimbleGen array application for small, degraded, and compromised samples. Designed to meet MAQC standards, it will explore input sample capabilities. Using NuGEN WT-Ovation Systems for amplification and labeling, […]
LEXINGTON, Mass., Nov 05, 2008 — RainDance Technologies, Inc., a provider of innovative microdroplet-based solutions for human health and disease research, today announced that it has shipped its new RDT 1000 instrument and Sequence Enrichment application to The Genome Center (GC) at the Washington University School of Medicine in St. Louis, a world leader in […]
London, UK, 4 November 2008 – Smiths Detection today announces that it is developing a rapid diagnostic system, initially for use in hospital screening programmes for infectious diseases such as MRSA and Clostridium difficile. The Bio-Seeq system will provide easy-to-use tests suitable for either a laboratory or Point of Care setting where it can be […]
Researchers from the Ghent University Hospital in Belgium and Applied Biosystems Inc. (NYSE:ABI) have published a study demonstrating the effectiveness of a new method for profiling microRNAs in small samples. The study, entitled “High-throughput stem-loop RT-PCR miRNA expression profiling using minute amounts of input RNA,” describes the simultaneous profiling of 450 human microRNAs from samples […]
Roche Diagnostics and Exiqon A/S, Vedbaek, Denmark, a provider of high-value gene expression analysis products, announced that they have entered into a license agreement for use of SYBR Green reagent in PCR. Under the terms of the agreement, Exiqon obtains from Roche a non-exclusive license to use SYBR Green I in Real Time PCR. SYBR […]
Applied Biosystems Inc. (NYSE:ABI) today announced the worldwide availability of a new universal genotyping reagent solution that accelerates the generation of high-quality genotyping data for a host of life science applications. The TaqMan(R) Sample-to-SNP(TM) Kit enables scientists who conduct genetic disease investigations, cancer research, transgenic animal studies, plant research, and agricultural seed selection to prepare […]
ST. LOUIS, Oct. 28 — Sigma-Aldrich (Nasdaq: SIAL) today announced the launch of its TransPlex(R) Whole Transcriptome Amplification (WTA2) technology (https://www.sigma.com/wta). TransPlex technology is believed to be the fastest, most sensitive and robust method available for amplifying total RNA from a variety of sample tissue sources such as animals, plants, and microorganisms. Optimized for formalin-fixed […]
Applied Biosystems Inc. (NYSE:ABI) today announced that it has expanded its portfolio of research tools that enable scientists to conduct gene expression analysis with limited sample materials. The new TaqMan(R) PreAmp Pools are pre-configured sets of reagents that allow scientists to amplify small amounts of RNA from biological samples in order to conduct comprehensive gene […]
Enigma Diagnostics Limited is a private UK based company specialising in developing the next generation of rapid molecular diagnostic instrument platforms for decentralised and point-of-care settings. Enigma’s innovative and proprietary technology combines the speed and sensitivity of real-time PCR (polymerase chain reaction) with the simplicity needed for field-based, decentralised and point-of-care tests providing results from […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
